Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 6% in the afternoon session after the U.S. Food and Drug Administration (FDA) approved a competing blood-based test for prostate ...

By signing up to the service, Nucleus Genomics will profile DNA sequences of embryos and allow would-be parents to review ...

Tempus AI Inc. (NASDAQ:TEM) is among the top 10 stocks to buy from Cathie Wood’s stock portfolio. As of the end of September ...

Disease development is often shaped by genetics, with how much or how little a gene is expressed influencing disease risk.

Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 0.4% in the afternoon session after the company shared ...

Future tech 2030 will reshape daily life with AI, quantum computing, autonomous vehicles, and more. Stay ahead with top tech ...

So, even via the more modest predictions, people will be able to double their longevity. When you reach 100 years old, you ...

A team of researchers from the Germans Trias i Pujol Research Institute (IGTP) and Institut Català d'Oncologia (ICO) has ...

BOSTON - Complete Genomics and SOPHiA GENETICS (NASDAQ:SOPH) announced Tuesday a collaboration to launch cancer genomic testing solutions that combine SOPHiA’s AI-powered analytics with Complete ...

Scientists for Genetic Diversity (SGD) have termed the FAO’s proposal to enhance Multilateral System on Access and Benefit ...

"People often think cardamom is a lucrative crop - it may be. But it's also the toughest crop a farmer can cultivate," says ...